Election 2014
SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Glenmark Pharma

Glenmark Pharma

BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Apr 17, 17:00
582.45
-0.65 (-0.11%)
VOLUME 10,744
AVERAGE VOLUME
5-Day 25,648
10-Day 66,820
30-Day 42,843
VOLUME SHOCKER
5-Day 25,648
10-Day 66,820
30-Day 42,843
Prev. Close
583.10
Open Price
585.00
Bid PRICE (QTY.)
582.45 (104)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 578.10 590.00
52 Wk Low/High 467.50 612.00
LIVE
NSE
Apr 17, 17:00
583.70
-0.05 (-0.01%)
VOLUME 254,066
AVERAGE VOLUME
5-Day 333,251
10-Day 773,160
30-Day 566,442
VOLUME SHOCKER
5-Day 333,251
10-Day 773,160
30-Day 566,442
Prev. Close
583.75
Open Price
586.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
583.70 (64)
Today’s Low/High 580.80 589.75
52 Wk Low/High 468.00 613.35
Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Rahul Gandhi

575.79 -0.44 -0.08%

54599

Bought today

50837

Sold today

0.21%

User holding

Glenmark
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying Glenmark. What's your call on Glenmark today? Read Investor view

MARKET CAP (Rs Cr)
15,797.42
*P/E
43.05
*BOOK VALUE (Rs)
93.03
DIV (%)
200.00%
Market Lot
1
INDUSTRY P/E
28.52
*EPS (TTM)
13.53
*P/C
40.28
*PRICE/BOOK
6.26
DIV YIELD.(%)
0.34%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
69.75 new
DELIVERY AVERAGES
3-Day 59.21%
5-Day 58.64%
8-Day 68.54%
* Based on standalone numbers
Track Glenmark on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Glenmark today?
Test your strategy with virtual money on Moneybhai
F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 495.45 585.00  
High Price 497.00 590.00  
Low Price 480.70 578.10  
Last Price 484.80 582.45 20.14
Volume 31,900 10,744 -66.32
Simple Moving Averages
Days BSE NSE
30 538.16 538.42
50 531.38 531.47
150 534.26 534.44
200 544.35 544.66

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Glenmark

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Dec '13)
(Sep '13)
Net Sales 1,601.22 1,463.01
Other Income 5.08 13.40
PBDIT 370.05 329.09
Net Profit 214.33 157.30

Annual Report

Download in PDF format 2013 |2012 |2011 |2010
Balance Sheet
(Sep '13)
(In Rs Cr)
Total Share Capital 27.09
Net Worth 2523.18
Total Debt 308.85
Net Block 279.18
Investments 1294.33
Net Current Assets 1089.61
Total Assets 2832.02
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 624.30 1.58 653.10 462.50 129,302.76
Dr Reddys Labs 2556.00 0.66 2939.80 1904.15 43,479.83
Lupin 955.25 0.23 1012.00 685.80 42,831.10
Cipla 400.60 0.96 450.00 375.00 32,165.03
GlaxoSmithKline 2497.40 -0.43 3054.40 2225.00 21,153.73
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 13Sep' 13Jun' 13Mar' 13
Promoter48.3048.3148.3048.31
FII33.1333.4933.8932.40
DII7.517.377.088.12
Others11.0610.8310.7311.17
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road,
City
Mumbai
State
Maharashtra
Pin Code
400026
Tel. No.
022-40189999 022-40189879
Fax No.
022-40189986
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Andhra Pradesh
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
Glenn Saldanha
Chairman & Managing Director
Rajesh V Desai
Executive Director & CFO
Cherylann Pinto
Director - Corporate Affairs
D R Mehta
Non Executive Director
Bernard Munos
Non Executive Director
Message Board & Community

About Glenmark

Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 15,797.42 crore.The company has reported a consolidated sales of Rs 1,601.22 crore and a Net Profit of Rs 214.33 crore for the quarter ended Dec 2013.

The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh V Desai - Executive Director & CFO, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, Bernard Munos - Non Executive Director, J F Ribeiro - Non Executive Director, Brian W Tempest - Non Executive Director, Sridhar Gorthi - Non Executive Director, Hocine Sidi Said - Non Executive Director, N B Desai - Non Executive Director.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Glenmark